Thursday, July 9, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Relay Therapeutics, Inc.”

12 pharma patents match "Relay Therapeutics, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 12
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 12 pharmaceutical patents matching "Relay Therapeutics, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

12 results for “Relay Therapeutics, Inc.” · 30,257 patents in full index Clear search

  1. US 12331056

    SHP2 phosphatase inhibitors and methods of use thereof

    Relay Therapeutics, Inc. · Granted Jun 17, 2025 · Expires Jun 12, 2045

    granted
  2. US 12219327

    Substituted isoindolines as PI3K-alpha inhibitors

    Relay Therapeutics, Inc. · Granted Feb 4, 2025 · Expires Jan 30, 2045

    granted
  3. US 12152034

    FGFR inhibitors and methods of making and using the same

    Relay Therapeutics, Inc. · Granted Nov 26, 2024 · Expires Nov 21, 2044

    granted
  4. US 12138263

    Pyrazolo[3,4-b]pyrazine SHP2 phosphatase inhibitors and methods of use thereof

    Relay Therapeutics, Inc. · Granted Nov 12, 2024 · Expires Nov 7, 2044

    granted
  5. US 12084447

    SHP2 phosphatase inhibitors and methods of use thereof

    Relay Therapeutics, Inc. · Granted Sep 10, 2024 · Expires Sep 5, 2044

    granted
  6. US 11890281

    SHP2 phosphatase inhibitors and methods of making and using the same

    Relay Therapeutics, Inc. · Granted Feb 6, 2024 · Expires Feb 1, 2044

    granted
  7. US 11780845

    FGFR inhibitors and methods of use thereof

    Relay Therapeutics, Inc. · Granted Oct 10, 2023 · Expires Oct 5, 2043

    granted
  8. US 11701354

    Pyrazolo[3,4-b]pyrazine derivatives as SHP2 phosphatase inhibitors

    Relay Therapeutics, Inc. · Granted Jul 18, 2023 · Expires Jul 13, 2043

    granted
  9. US 11629145

    SHP2 phosphatase inhibitors and methods of use thereof

    Relay Therapeutics, Inc. · Granted Apr 18, 2023 · Expires Apr 13, 2043

    granted
  10. US 11591336

    Substituted pyrazolo[3,4-b]pyrazines as SHP2 phosphatase inhibitors

    Relay Therapeutics, Inc. · Granted Feb 28, 2023 · Expires Feb 23, 2043

    granted
  11. US 11529347

    SHP2 phosphatase inhibitors and methods of use thereof

    Relay Therapeutics, Inc. · Granted Dec 20, 2022 · Expires Dec 15, 2042

    granted
  12. US 10934302

    SHP2 phosphatase inhibitors and methods of use thereof

    Relay Therapeutics, Inc. · Granted Mar 2, 2021 · Expires Feb 25, 2041

    granted